Time to diagnosis and determinants of diagnostic delays of people living with a rare disease: results of a Rare Barometer retrospective patient survey
- PMID: 38755315
- PMCID: PMC11369105
- DOI: 10.1038/s41431-024-01604-z
Time to diagnosis and determinants of diagnostic delays of people living with a rare disease: results of a Rare Barometer retrospective patient survey
Abstract
Timely diagnosis is one of the most serious challenges faced by people living with a rare disease (PLWRD), and this study estimates that in Europe, the average total diagnosis time (TDT) is close to 5 years. We investigated the duration of the TDT for PLWRD in Europe, the difficulties associated with their diagnosis odyssey and the main determinants of diagnosis delays for all rare diseases (RD). We conducted a survey of PLWRD and their families using Rare Barometer, the survey initiative of EURORDIS-Rare Diseases Europe. In geographical Europe, we surveyed 6507 people living with 1675 RD in 41 countries. We then performed a descriptive analysis and ordinal logistic regressions to identify the main determinants of diagnosis delays. Average TDT is 4.7 years. 56% of respondents were diagnosed more than 6 months after a first medical contact. The main determinants of diagnosis delays are symptom onset before 30 years of age, especially during childhood (OR = 3.11; 95% CI: 2.4-4.0) and adolescence (OR = 4.79; 95% CI: 3.7-6.2), being a woman (OR = 1.22; 95% CI:1.1-1.4), living in Northern Europe (OR = 2.15; 95% CI:1.8-2.6) or Western Europe (OR = 1.96; 95% CI:1.6-2.3), the number of healthcare professionals consulted (OR = 5.15; 95% CI:4.1-6.4), misdiagnosis (OR = 2.48; 95% CI:2.1-2.9), referral to a centre of expertise (OR = 1.17; 95% CI:1.0-1.3), unmet needs for psychological support (OR = 1.34; 95% CI:1.2-1.5) and financial support (OR = 1.16; 95% CI:1.0-1.3), having a genetic disease (OR = 1.33; 95% CI:1.1-1.5) and a family history of an RD (OR = 1.36; 95% CI:1.1-1.6). These determinants can inform policies and actions to improve access to diagnosis for all PLWRD.
© 2024. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures



Similar articles
-
Australian children living with rare diseases: experiences of diagnosis and perceived consequences of diagnostic delays.Orphanet J Rare Dis. 2017 Apr 11;12(1):68. doi: 10.1186/s13023-017-0622-4. Orphanet J Rare Dis. 2017. PMID: 28399928 Free PMC article.
-
[Diagnostic delay of rare diseases in Europe and in Hungary].Orv Hetil. 2012 Jul 29;153(30):1185-90. doi: 10.1556/OH.2012.29418. Orv Hetil. 2012. PMID: 22835635 Hungarian.
-
The management of rare disease patients from a grassroot perspective: the role of patients' organizations in the global recognition of rare diseases in Cameroon.Pan Afr Med J. 2024 Feb 13;47:64. doi: 10.11604/pamj.2024.47.64.38226. eCollection 2024. Pan Afr Med J. 2024. PMID: 38681114 Free PMC article.
-
Identification of strengths and weaknesses of the healthcare system for persons living with rare diseases in Catalonia (Spain), and recommendations to improve its comprehensive attention: the "acERca las enfermedades raras" project.Orphanet J Rare Dis. 2025 Jan 29;20(1):42. doi: 10.1186/s13023-024-03518-x. Orphanet J Rare Dis. 2025. PMID: 39875900 Free PMC article.
-
Rare diseases social epidemiology: analysis of inequalities.Adv Exp Med Biol. 2010;686:223-50. doi: 10.1007/978-90-481-9485-8_14. Adv Exp Med Biol. 2010. PMID: 20824449 Review.
Cited by
-
Diagnosis of Inherited Metabolic Disease in Older Patients: A Systematic Literature Review.J Inherit Metab Dis. 2025 May;48(3):e70038. doi: 10.1002/jimd.70038. J Inherit Metab Dis. 2025. PMID: 40406818 Free PMC article. Review.
-
Helping the medicine go down: the role of the healthcare professional in a young person's experience of achalasia, a rare oesophageal motility disorder.Orphanet J Rare Dis. 2025 Feb 20;20(1):72. doi: 10.1186/s13023-025-03571-0. Orphanet J Rare Dis. 2025. PMID: 39972474 Free PMC article.
-
The cost of the diagnostic odyssey of patients with suspected rare diseases.Orphanet J Rare Dis. 2025 May 10;20(1):222. doi: 10.1186/s13023-025-03751-y. Orphanet J Rare Dis. 2025. PMID: 40349051 Free PMC article.
-
Hereditary angioedema diagnosis: Reflecting on the past, envisioning the future.World Allergy Organ J. 2025 May 14;18(6):101060. doi: 10.1016/j.waojou.2025.101060. eCollection 2025 Jun. World Allergy Organ J. 2025. PMID: 40487881 Free PMC article. Review.
-
The impact of rare diseases on the quality of life in paediatric patients: current status.Front Public Health. 2025 Mar 24;13:1531583. doi: 10.3389/fpubh.2025.1531583. eCollection 2025. Front Public Health. 2025. PMID: 40196857 Free PMC article. Review.
References
-
- Kole A, Hedley V, et al. Recommendations from the Rare 2030 Foresight Study: the future of rare diseases starts today. 2021. Available from: https://download2.eurordis.org/rare2030/Rare2030_recommendations.pdf. Accessed 20 Mar 2024.
-
- Kole A, Faurisson F, The voice of 12,000 patients. Experiences and expectation of rare disease patients on diagnosis and care in Europe. EURORDIS. 2009. Available from: https://www.eurordis.org/publications/the-voice-of-12000-patients/. Accessed 20 Mar 2024.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous